Table 2.
Comparison of the percentage of grey value reduction between PCR and non-PCR groups.
| PCR (n = 32) | non-PCR (n = 79) | t | P | |
|---|---|---|---|---|
| CC view grey value before chemotherapy | 123.97 ± 38.81 | 132.40 ± 37.48 | − 1.063 | 0.290 |
|
After two cycles of chemotherapy |
73.48 ± 9.72 | 105.43 ± 34.01 | − 5.216 | < 0.001 |
| Reduction percentage (%) | 36.53 ± 17.54 | 19.63 ± 13.64 | 5.430 | < 0.001 |
|
MLO view grey value before chemotherapy |
116.71 ± 27.98 | 129.87 ± 34.40 | − 1.920 | 0.057 |
|
After two cycles of chemotherapy |
80.70 ± 17.25 | 106.59 ± 32.33 | − 4.282 | < 0.001 |
| Reduction percentage (%) | 28.90 ± 14.23 | 17.01 ± 14.46 | 3.942 | < 0.001 |